WHO Pharmaceuticals Newsletter 2003, No. 04
(2003; 13 pages) Voir le document au format PDF
Table des matières
Ouvrir ce répertoire et afficher son contenuREGULATORY MATTERS
Fermer ce répertoireSAFETY OF MEDICINES
Afficher le documentATYPICAL ANTI-PSYCHOTICS - Reports of hypertension
Afficher le documentBOTULINUM A - Patients misled over safety
Afficher le documentCHELIDONIUM MAJUS - Statement to advise use under supervision
Afficher le documentCYCLO-OXYGENASE (COX)-2 INHIBITORS - Reports of hepatotoxicity
Afficher le documentETONOGESTREL - Vaginal bleeding with sub-dermal implant
Afficher le documentFLUTICASONE - ADR update
Afficher le documentGATIFLOXACIN - Reports of abnormal glucose metabolism
Afficher le documentHORMONE REPLACEMENT THERAPY (HRT) - ‘Million Women Study’ confirms breast cancer association
Afficher le documentMEDROXY-PROGESTERONE - Reports of contraception failure with depot preparations
Afficher le documentMEFLOQUINE - Patient guide warns of psychiatric adverse events
Afficher le documentMETHOTREXATE - New solutions to prevent fatalities/adverse events
Afficher le documentMINOCYCLINE - Hepatic reactions
Afficher le documentPIPERACILLIN - Serum methotrexate monitoring advised during concomitant therapy
Afficher le documentRIFAMPICIN & PYRAZINAMIDE - Warning against use in latent tuberculosis
Afficher le documentSELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs): Reports of hyponatraemia
Afficher le documentSIBUTRAMINE - Serotonin syndrome
Afficher le documentTICLOPIDINE - No decrease in ADR reports
Afficher le documentVIGA/VIGA FOR WOMEN - Presence of sildenafil
Afficher le documentWARFARIN & MICONAZOLE - Reminder about interaction
Ouvrir ce répertoire et afficher son contenuDRUGS IN THE NEWS
 

WARFARIN & MICONAZOLE - Reminder about interaction

New Zealand. In a Prescriber Update article prescribers and pharmacists in New Zealand have been reminded of the potentially serious interaction between miconazole oral gel (Daktarin oral gel) and warfarin leading to clinically significant elevations in INR. Six cases of an interaction between oral miconazole and warfarin resulting in INR increases have been reported in New Zealand. In four of these cases patients presented with haemarthrosis, haematuria, haemoptysis or epistaxis. INR values ranged from 7.5 to 18 and were > 10 in all patients with bleeding symptoms. The article also highlights reports of the interaction in Australia. There has also been one report of an interaction between topical miconazole cream and warfarin in Australia.

Reference:

Medsafe Editorial Team. Miconazole - warfarin interaction reminder. Prescriber Update: Therapeutics Section 24: 12, Jun 2003.

 

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013